Patents by Inventor David Sackler

David Sackler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melt-extruded orally administrable opioid formulations
    Publication number: 20050089568
    Abstract: Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
    Type: Application
    Filed: September 16, 2003
    Publication date: April 28, 2005
    Inventors: Benjamin Oshlack, Mark Chasin, Hua-Pin Huang, David Sackler
  • Melt-extruded orally administrable opioid formulations
    Patent number: 6743442
    Abstract: Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: June 1, 2004
    Assignee: Euro-Celtique, S.A.
    Inventors: Benjamin Oshlack, Mark Chasin, Hua-Pin Huang, David Sackler
  • Melt-extruded orally administrable opioid formulations
    Publication number: 20040081694
    Abstract: Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
    Type: Application
    Filed: October 21, 2003
    Publication date: April 29, 2004
    Applicant: Euro-Celtique, S.A.
    Inventors: Benjamin Oshlack, Mark Chasin, Hua-Pin Huang, David Sackler
  • Melt-extruded orally administrable opioid formulations
    Publication number: 20010036476
    Abstract: Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.
    Type: Application
    Filed: February 6, 2001
    Publication date: November 1, 2001
    Applicant: Euro-Celtique S.A.
    Inventors: Benjamin Oshlack, Mark Chasin, Hua-Pin Huang, David Sackler
  • Melt-extruded orally administrable opioid formulations
    Patent number: 6261599
    Abstract: Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques disclosed.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: July 17, 2001
    Assignee: Euro-Celtique, S.A.
    Inventors: Benjamin Oshlack, Mark Chasin, Hua-Pin Huang, David Sackler
  • Transdermal patch for comparative evaluations
    Patent number: 5733571
    Abstract: A transdermal patch useful for evaluating the therapeutic effectiveness of a transdermally delivered medicinal agent is disclosed. The patch includes a substantially impermeable backing layer, a delivery layer containing a medicament and a substantially impermeable blocking layer. The delivery layer is arranged between the backing and blocking layers to prevent the release of the medicament contents from the delivery layer when the transdermal patch is affixed to the skin of a mammal. In alternative embodiments, non-transdermal placebo systems such as oral dosage forms which are coated with substantially impermeable layers to create virtually identical placebos of active oral delivery systems such as tablets, capsules and osmotic tablets are disclosed. Methods of comparing the therapeutic effectiveness of active dosage forms, i.e. transdermal units containing a medicament to placebo or to comparable active agents in either similar or different delivery systems are also disclosed.
    Type: Grant
    Filed: January 5, 1996
    Date of Patent: March 31, 1998
    Assignee: Euro-Celtique, S.A.
    Inventor: David Sackler